Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia - Related Studies

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

This study has been completed.

Study NCT00005808. Last updated on September 6, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cervical Cancer
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Carcinoma in Situ
		Cervical Intraepithelial Neoplasia
		Precancerous Conditions
		Uterine Cervical Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Genital Diseases, Female
		Genital Neoplasms, Female
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Urogenital Neoplasms
		Uterine Cervical Diseases
		Uterine Diseases
		Uterine Neoplasms

4	Interventions listed in this trial
		motexafin lutetium

5	More general drug interventions related to this trial
		Dermatologic Agents
		Pharmacologic Actions
		Photosensitizing Agents
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		University of Pittsburgh
		National Cancer Institute (NCI)